Equity Research, Broker Reports, and media content on Verona Pharma plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Verona Pharma plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Verona Pharma plc

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Verona Pharma plc. We currently have 119 research reports from 6 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 0.00/0.00
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: 0m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
29Oct20 07:00 GNW Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020
28Oct20 11:01 GNW Verona Pharma plc : Update on AIM Delisting
23Oct20 17:30 RNS Verona Pharma
22Oct20 07:00 GNW Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update
13Oct20 07:00 GNW Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020
23Sep20 09:06 GNW Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
21Sep20 07:00 GNW Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
  • Frequency of research reports


  • Research reports on

    Verona Pharma plc

  • Providers covering

    Verona Pharma plc